SCHEMBL13889296

SCHEMBL13889296

N#CSc1ccc(Oc2ccc(C#N)cc2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.51
PARP15 Q460N3 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
POLB P06746 2/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
IL18 Q14116 1/20 0.41
TTBK1 Q5TCY1 1/20 0.39
TTBK2 Q6IQ55 1/20 0.39
SCN9A Q15858 2/20 0.39
KCNH2 Q12809 1/20 0.39
SCN5A Q14524 1/20 0.39
CYP11B1 P15538 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13889297 0.78 CYP19A1 (0.56) CYP19A1LMNATTBK1TTBK2CYP11B1
SCHEMBL13895544 0.78 CYP19A1 (0.59) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL4376200 0.75 CYP19A1 (0.60) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL4480751 0.75 CYP19A1 (0.56) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL15584627 0.75 CYP19A1 (0.56) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL2707449 0.75 CYP19A1 (0.56) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL8852392 0.74 PARP15 (0.63) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL7041250 0.74 PARP15 (0.63) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL15006214 0.71 CYP19A1 (0.51) CYP19A1PARP15PARP10PARP2POLB
SCHEMBL8238126 0.70 PARP15 (0.51) CYP19A1PARP15PARP10PARP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7517992-B2 Non-nucleoside reverse transcriptase inhibitors MEDIVIR AB (SE) 2009-04-14 US disclosed